학술논문

Daratumumab monotherapy in patients with heavily pretreated relapsed or refractory multiple myeloma: final results from the phase 2 GEN501 and SIRIUS trials
Document Type
Article
Source
In The Lancet Haematology June 2020 7(6):e447-e455
Subject
Primary Research
Articles
Language
ISSN
2352-3026